Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 288 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Apogee Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 139
- +54 vs. Q4 2023
- Shares held
- 52.9M
- +11.1M (+26.7%) vs. Q4 2023
- Total value
- $3.52B
- +$2.35B (+202.2%) vs. Q4 2023
- New holders
- 62
- 52 more added
- Sold out
- 8
- 19 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 288 | $8.93B |
| Q1 2026 | 224 | $6.64B |
| Q4 2025 | 207 | $5.27B |
| Q3 2025 | 174 | $2.37B |
| Q2 2025 | 183 | $2.51B |
| Q1 2025 | 169 | $2.30B |
| Q4 2024 | 158 | $2.62B |
| Q3 2024 | 139 | $3.29B |
| Q2 2024 | 139 | $2.13B |
| Q1 2024 | 139 | $3.52B |
| Q4 2023 | 85 | $1.16B |
| Q3 2023 | 73 | $848.7M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Apogee Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | 137,267 | $9.12M | 0.00% | +71,584+109.0% | Added |
| TD Asset Management Inc | 148,206 | $9.85M | 0.01% | +47,360+47.0% | Added |
| Artal Group S.A. | 152,500 | $10.1M | 0.26% | +152,500 | New |
| Platinum Investment Management Ltd | 167,878 | $11.2M | 0.45% | −115,805−40.8% | Reduced |
| Adage Capital Partners GP, L.L.C. | 175,000 | $11.6M | 0.02% | −350,000−66.7% | Reduced |
| Blackstone Group Inc. | 230,000 | $15.3M | 0.07% | −121,810−34.6% | Reduced |
| Charles Schwab Investment Management Inc | 240,766 | $16.0M | 0.00% | +85,001+54.6% | Added |
| Commodore Capital LP | 290,000 | $19.3M | 1.29% | +40,000+16.0% | Added |
| Jennison Associates LLC | 302,892 | $20.1M | 0.01% | +199,148+192.0% | Added |
| Farallon Capital Management, L.L.C. | 305,000 | $20.3M | 0.12% | +305,000 | New |
| Northern Trust Corp | 324,224 | $21.5M | 0.00% | +147,451+83.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 329,000 | $21.9M | 0.38% | +329,000 | New |
| Paradigm Biocapital Advisors LP | 330,000 | $21.9M | 0.77% | +330,000 | New |
| First Turn Management, LLC | 379,803 | $25.2M | 3.78% | +379,803 | New |
| Avidity Partners Management LP | 384,893 | $25.6M | 0.91% | +384,893 | New |
| Bank of America Corp | 396,778 | $26.4M | 0.00% | −92,431−18.9% | Reduced |
| Great Point Partners LLC | 400,000 | $26.6M | 4.14% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 487,200 | $32.4M | 0.09% | −221,200−31.2% | Reduced |
| Affinity Asset Advisors, LLC | 592,093 | $39.3M | 6.40% | +55,000+10.2% | Added |
| Woodline Partners LP | 702,421 | $46.7M | 0.43% | +376,319+115.4% | Added |
| OrbiMed Advisors LLC | 718,901 | $47.8M | 0.94% | −559,000−43.7% | Reduced |
| Alliancebernstein L.P. | 745,118 | $49.5M | 0.02% | +734,478+6,903.0% | Added |
| Geode Capital Management, LLC | 761,024 | $50.6M | 0.00% | +319,552+72.4% | Added |
| Darwin Global Management, Ltd. | 832,198 | $55.3M | 7.36% | +832,198 | New |
| Franklin Resources Inc | 1,035,380 | $68.8M | 0.02% | −54,400−5.0% | Reduced |
| Price T Rowe Associates Inc | 1,170,327 | $77.8M | 0.01% | +399,646+51.9% | Added |
| State Street Corp | 1,347,797 | $89.6M | 0.00% | +968,527+255.4% | Added |
| Braidwell LP | 1,842,515 | $122.4M | 3.95% | +1,161,414+170.5% | Added |
| Vanguard Group Inc | 1,868,666 | $124.2M | 0.00% | +705,795+60.7% | Added |
| Ra Capital Management, L.P. | 1,977,901 | $131.4M | 1.67% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 2,048,647 | $136.1M | 14.84% | −892,529−30.3% | Reduced |
| Perceptive Advisors LLC | 2,060,395 | $136.9M | 2.41% | +232,494+12.7% | Added |
| Driehaus Capital Management LLC | 2,063,763 | $137.1M | 1.37% | +734,699+55.3% | Added |
| Wellington Management Group LLP | 2,269,897 | $150.8M | 0.03% | +678,419+42.6% | Added |
| Deep Track Capital, LP | 2,323,456 | $154.4M | 4.44% | 00.0% | Unchanged |
| RTW Investments, LP | 2,467,591 | $164.0M | 2.42% | +325,000+15.2% | Added |
| BlackRock Inc. | 2,809,825 | $186.7M | 0.00% | +1,165,788+70.9% | Added |
| FMR LLC | 6,743,902 | $448.1M | 0.03% | +1,725,022+34.4% | Added |
| VR Adviser, LLC | 8,493,321 | $564.4M | 26.85% | 00.0% | Unchanged |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −101,202−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −18,344−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −7,353−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −12−100.0% | Sold out |